12

A leading inhalation expert

Iconovo is a Swedish CDMO company, offering innovative inhalation platforms to the international pharmaceutical industry. We have several types of patented dry powder inhaler devices, and inhouse formulation, for the development of complete inhalation products within both new pharmaceuticals and generic medicine. As a leading inhaler expert, Iconovo is the knowledgeable partner you need to accelerate opportunities and time to market.

Latest news from Iconovo

Iconovo files patent application for inhaled GLP-1 products and initiates development of new obesity treatments

Iconovo AB (publ), which develops complete inhalation products for a global market, today announces that the company has filed a broad patent application…
Read more

Iconovo releases Q1-2024 report

“We have made a flying start into 2024.”, says Johan Wäborg, CEO at Iconovo. CEO's MESSAGES. - RAMPING UP IN 2024 - ICONOVO EXPANDS BUSINESS…
Read more

Iconovo’s partner Monash University has completed enrollment in a Phase I clinical trial of inhaled oxytocin in ICOone

Iconovo AB (publ), which develops complete inhalation products for a global market, today announces that the clinical phase I study of oxytocin in…
Read more
Read all news

Meet us

BUSINESS MEETINGS

Bio International Convention

June 3-6, 2024

San Diego

NLS Days 

September 17-19, 2024

Malmö

CPhI  

October 8-10, 2024

Milan

MVIC Inhalation Symposium 

October 16-17, 2024

Lund

INVESTOR MEETINGS

Redeye Life Science Days 

November 28, Stockholm

PARTNERSHIP

Your innovative inhaler partner

We are a specialized CDMO that develops inhalation products in our patented, innovative inhalers, supporting customers in bringing their inhaled treatments to market.

Learn more

PRODUCTS

Four differentiated technical platforms

We develop inhaled medicines from your drug substance as your complete inhalation partner. We take you all the way through your pharmaceutical product development, from idea to finalized inhalation product. Our strength is the integrated development of inhaler and dry powder formulation. Four differentiated technical inhaler platforms can be optimized with your unique dry powder formulation, and we also assist with manufacturing of clinical trial material in early clinical trials and technical documentation for registrations.

Learn more

DEVELOPMENT RESOURCES

Engineering and pharmaceutical expertise

Iconovo has an integrated development process, with all competences and facilities inhouse. With a unique combination of engineering and pharmaceutical expertise, our capabilities include devices, formulation, pharmaceutical analysis, and advisory services.

Learn more

Stay up to date with Iconovo’s news and press releases

SIGN UP